Cargando…
Artificial intelligence in pancreatic cancer
Pancreatic cancer is the deadliest disease, with a five-year overall survival rate of just 11%. The pancreatic cancer patients diagnosed with early screening have a median overall survival of nearly ten years, compared with 1.5 years for those not diagnosed with early screening. Therefore, early dia...
Autores principales: | Huang, Bowen, Huang, Haoran, Zhang, Shuting, Zhang, Dingyue, Shi, Qingya, Liu, Jianzhou, Guo, Junchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576619/ https://www.ncbi.nlm.nih.gov/pubmed/36276650 http://dx.doi.org/10.7150/thno.77949 |
Ejemplares similares
-
The Present and Future of Artificial Intelligence in Urological Cancer
por: Liu, Xun, et al.
Publicado: (2023) -
Artificial Intelligence-Driven Diagnosis of Pancreatic Cancer
por: Hameed, Bahrudeen Shahul, et al.
Publicado: (2022) -
Artificial intelligence for the management of pancreatic diseases
por: Gorris, Myrte, et al.
Publicado: (2020) -
Hyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic Cancer
por: Enriquez, José S, et al.
Publicado: (2021) -
Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence
por: Granata, Vincenza, et al.
Publicado: (2023)